Feb. 2023

Our Kick-Off meeting for ELMUMY Horizon Cancer Mission research programme was held on February 8^th, 2023. ELMUMY aims at yielding clinically actionable molecular features that could improve patient management of multiple myeloma. Mosaiques applies its validated CE-MS technology and contributes with biomarkers to predict progression of multiple myeloma.

LINK: www.elmumy.eu